As I noted above, Compass Pathways released results from its 6-week phase 3 COMP005 trial, which used synthetically developed psilocybin for patients with treatment-resistant depression [TRD].

Compass Pathways anticipates sharing 26-week data for COMP005 once all participants in the COMP006 trial have completed part A of the COMP006 trial. The 26-week data from COMP006 is expected in ...

Browse 6,900+ pics of a compass rose stock illustrations and vector graphics available royalty-free, or start a new search to explore more great stock images and vector art. Travel and Nautical - ...

Download this Compass vector illustration now. And search more of iStock's library of royalty-free vector art that features Arrow Symbol graphics available for quick and easy download.

Since its shift from Nokia to HMD, Human Mobile Devices has been launching some interesting smartphones and feature phones. These phones focus on quality and practicality instead of raw power and ...

Compass is headquartered in London, UK, with offices in New York in the U.S. We envision a world where mental health means not just the absence of illness but the ability to thrive. Forward-looking ...

Save with these 10 Autodesk promo codes on AutoCAD, Autodesk Fusion 360, and more. All coupon content is created by PC Gamer. We may earn a commission if you buy through our links. More Info.

Compass Pathways plc (NASDAQ: CMPS) announced Monday that its Phase 3 COMP005 trial for COMP360, a synthetic formulation of psilocybin, met its primary endpoint in patients with treatment-resistant ...